Lymphatic in Biological Technology

Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology

... special double issue (Volume 6, Number 3-4) of lymphatic Research and Biology includes a series of ... physician-scientists of his generation. lymphatic Research and Biology is a peer-reviewed ... and Chair of the Scientific Advisory Board of the lymphatic Research Foundation. Dr. Rockson, who is the ...

LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease

... initiation, the international effort to eliminate lymphatic filariasis (LF) has made unprecedented strides ... sponsored Global Program to Eliminate lymphatic Filariasis, which has proven to be a model for ... Dr. Mwele Malecela, PhD, Director of the Tanzania lymphatic Filariasis Program and Chair of the Global ...

New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema

... side effects such as lymphedema (swelling due to blockage in the lymphatic system). Staffed by a dedicated team of multilingual clinical case ... due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and ...

Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug

... proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be ... proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be ...

New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma

... Project Manger PJ Hooper, who oversees a Gates Foundation grant supporting NTD integration research, has conducted operational research on lymphatic Filariasis and NTDs for another Gates grant to the Global Alliance to Eliminate LF. Program Accounting Manager Edward Nyankson has 16 years ...

Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million

... Non-Hodgkin's Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms - aggressive NHL, a rapidly spreading ...

FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review

... Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading ...

High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma

... Non-Hodgkin's Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading ...

Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy

... Non-Hodgkin's Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading ...

FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion

... Non-Hodgkin's Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms - aggressive NHL, a rapidly spreading ...

CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application

... Non-Hodgkin's Lymphoma Non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, a system of vessels that drains fluid from the body. NHL can be broadly classified into two main forms -- aggressive NHL, a rapidly spreading ...

Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons

... guided therapies for use in the operating room. Novadaq's proprietary ICG imaging systems can be used to visualize blood vessels, nerves and the lymphatic system during a variety of surgical procedures. Novadaq's SPY(R) Imaging System, commercially available worldwide, enables cardiac surgeons to ...

Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma

... Institute, an estimated 30,000 people in the United States will be diagnosed in 2007 with indolent NHL, a serious and slow growing cancer of the lymphatic system that is difficult to treat because patients are prone to relapse after treatment. "TREANDA is the lead product in our oncology pipeline and ...

Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)

... should exercise caution when using Synvisc in patients allergic to avian proteins, feathers, or egg products; who have evidence of venous or lymphatic stasis in the leg to be treated; or who have severe inflammation in the knee joint to be treated. Patients should be advised to avoid strenuous or ...

Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma

... and in four Phase II monotherapy clinical trials in hematological malignancies. About Hodgkin's Lymphoma Hodgkin's lymphoma (HL) is a cancer of the lymphatic system that begins in the lymph nodes and progresses to other organs, including the lungs, liver, bone and bone marrow. It is characterized by the ...

Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A

... Lymphangiogenesis refers to the formation of new lymphatic vessels. This process may occur in ... described. Measuring the density of lymphatic vessels has not been reliable due to a lack of sensitive lymphatic markers and antibodies. Furthermore, it does not ...

Cancer-fighting agent heads for clinical trials

... trials, it could treat forms of non-Hodgkin's lymphoma that are resistant to certain therapies. Non-Hodgkin's lymphoma is a cancer of the human lymphatic system, which is comprised of blood-filtering tissues that help fight infection and disease. Clinical trials will begin in the near future to see ...

Transformation of Nematodes With the Helios Gene Gun

... pathogenic filariae (Zahner, Hobom and Stirm, 1995), such as Wuchereria bancrofti or Brugia spp. These parasitic species cause a severe lymphatic disease called filariasis (elephantiasis), from which more than 100 million human beings suffer worldwide. ...

Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method

... associated with tumor dissemination. Spreading of tumor cells into the blood circulation from either primary tumors or subsequently from the lymphatic origin may be a result of dissemination of the primary tumor or a secondary event during tumor progression. Many of these cells reaching the ...